Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
Location: United States, North Carolina, Hillsborough
Employees: 1-10
Total raised: $35M
Founded date: 2018
Founders name: Eric Benner; Jason Kralic
Founders Related Locations: United States, North Carolina, Durham; United States, North Carolina, Raleigh; United States, North Carolina, Durham County; United States, Texas, The Woodlands
Investors 2
| Date | Name | Website |
| - | MassChalle... | masschalle... |
| - | Xontogeny | xontogeny.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.12.2022 | Series A | $35M | - |
Persons 2
| Date | First Name | Last Name | Title | Location | |||
| - | Eric | Benner | Co-Founder... | linkedin.c... | - | - | United Sta... |
| - | Jason | Kralic | Co-founder... | linkedin.c... | - | - | - |
Mentions in press and media 6
| Date | Title | Description |
| 19.12.2022 | Digital health news, funding round up in the prior week; December 19, 2022 | HistoSonics raised $100M; Memora Health and PeriGen partner; health spending reached $4.3T in 2021 Top Health News A Harris poll which asked respondents what data they would with a national database to prevent another public health emergenc... |
| 13.12.2022 | Tellus Therapeutics Raises $35M in Series A Financing | Tellus Therapeutics, a Dhuram, NC-based neonatal care company, raised $35M in Series A funding. The round was led by Perceptive Xontogeny Venture Fund. The company intends to use the funds for the development of TT-20 into clinical trials f... |
| 13.12.2022 | Tellus Therapeutics Nabs $35M Series A Funding | DURHAM, NC, Tellus Therapeutics announced today the closing of a Series A financing round of $35 million. >> Click here for more funding data on Tellus Therapeutics >> To export Tellus Therapeutics funding data to PDF and Ex... |
| 24.10.2019 | MassChallenge Awards over $1M in Cash Prizes to Top Boston and Rhode Island Startups | BOSTON, October 24, 2019 – MassChallenge, a global network of zero-equity startup accelerators, tonight awarded more than $1M to 12 startups from its 10th annual Boston accelerator and second annual Rhode Island accelerator. Through a partn... |
| 02.10.2019 | MassChallenge Boston Names Top 20 Startups in 2019 Cohort | October 2, 2019, BOSTON – MassChallenge, a global network of zero-equity startup accelerators, today announced the top 20 startups from its 2019 Boston program. These startups will now advance to the final judging round, where they’ll compe... |
| - | Tellus Therapeutics | “Tellus Therapeutics – –” |